Triolein [122-32-7]
Référence T3S0640-1ml
Conditionnement : 1mLx10mM(inDMSO)
Marque : TargetMol
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
Triolein
(Synonyms: Glycerol trioleate, Glycerine Trioleate) Copy Product Info
Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.
Cas No. 122-32-7
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.99%
Appearance:Liquid
Color:Transparent
COA HNMR HPLC
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy. |
| Synonyms | Glycerol trioleate, Glycerine Trioleate |
| Molecular Weight | 885.43 |
| Formula | C57H104O6 |
| Cas No. | 122-32-7 |
| Smiles | C(OC(CCCCCCC/C=C\CCCCCCCC)=O)(COC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O |
| Relative Density. | 0.91 g/cm3 (lit.) |
| Storage | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 75 mg/mL (84.7 mM), Sonication is recommended.  H2O: Insoluble | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.26 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||